We are monitoring the impact of COVID-19 & Recession alarm on Asia Pacific Renal Biomarkers Market Get in touch with us for detailed analysis Know More

Know More

Share on

Asia Pacific Renal Biomarkers Market Research Report - Segmented By Diagnostic Technique, Type & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, Growth, Forecasts | 2022 to 2027

Published: January, 2022
ID: 5225
Pages: 145

Asia Pacific Renal Biomarkers Market Size & Growth (2022 to 2027):

The Size of the Asia Pacific Renal Biomarkers Market was valued at USD 247.08 million in 2022 and estimated to grow at a CAGR of 9.24%, to reach USD 384.42 million by 2027 during the forecast period 2022 to 2027.

The increased incidence of numerous kidney-related disorders, the high prevalence of diabetes and high blood pressure, which are the primary causes of renal diseases, and rapid technological advancements in genetics, are driving the expansion of this market in the Asia Pacific. In addition, because of developments in computer technology, renal biomarker testing is now widely available and possible, even in small laboratories. 

Recent genetic findings have enabled researchers to utilize several platforms to study kidney disease in human populations. Renal biomarkers can also be used in genetic-level technological advancements to detect, diagnose, and treat kidney disease. Genetics analyses have become indispensable in clinical practice and research due to significant improvements in genomic technologies. 

The industry would also gain traction as more people develop chronic conditions like diabetes, obesity, and hypertension, linked to the slow loss of kidney function. However, they are time demanding and lack sensitivity and specificity. With the advancement of genomics, proteomics, transcriptomics, and metabolomics, novel diagnostic tools such as renal biomarkers should be willing to help in the early diagnosis of renal disorders.

The biomarker's expansion is projected to be hampered by a lack of validated innovative renal biomarkers and their failure to correlate with clinical outcomes. Most kidney biomarkers peak too late, making it difficult to link them to biological or clinical results. Today's renal biomarkers are more predictive of renal function than renal injury. 

They are influenced by non-renal factors, including gender, age, and drug status, making it more challenging to manage acute kidney injury (AKI). Low sensitivity and specificity of biomarkers are expected to hamper the Asia Pacific renal biomarkers market. For example, some renal biomarkers, such as L-18, are more specific but not particularly sensitive, whereas others, such as osteopontin, are empathetic but not specific. China is the world's industrial powerhouse with the leading raw material providers. The broad market breakdown induced by COVID-19 also affects the market's growth due to manufacturing closures, supply chain hurdles, and the economic crisis. 

This research report on the Asia Pacific Renal Biomarkers Market has been segmented and sub-segmented into the following categories.

By Diagnostic Technique:

  • Chemiluminescent Enzyme Immunoassay
  • Colorimetric Assay
  • Enzyme-Linked Immunosorbent Assay
  • Liquid Chromatography-Mass Spectrometry
  • Particle-Enhanced Turbidimetric Immunoassay

By Type:

  • Up-Regulated Proteins
  • Interleukin 18
  • Kidney injury molecule 1
  • Neutrophil gelatinase-associated lipocalin
  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, renal cancer can be detected early and treated before it progresses. The primary factors driving the Asia Pacific renal biomarkers market are the increased incidence of illnesses, a high elderly population, and the rising prevalence of numerous comorbidities. 

The China renal biomarkers market and India renal biomarkers market have the most significant share globally over the projection period in the Asia Pacific region.

In addition, introducing new products and assays throughout the predicted period will boost the industry's growth. Almost every pharmaceutical business has launched a molecular biomarker program, either through alliances or other means. According to the World Bank Group, China's healthcare spending reached 5.8% of GDP in 2016 and is predicted to quadruple by 2022. 

The renal biomarkers market is driven by solid expansion in healthcare spending and rising worldwide per capita income. In addition, the renal biomarkers market is expected to grow as healthcare infrastructure improves and government reimbursement programs are implemented.

KEY MARKET PLAYERS

Top Companies dominating the Asia Pacific Renal Biomarkers Market Profiled in the Report are Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Astute Medical Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Alere Inc., bioMérieux SA, and Randox Laboratories Ltd.,

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Diagnostic Technique    

       5.1.1 Introduction           

       5.1.2 Chemiluminescent Enzyme Immunoassay

       5.1.3 Colorimetric Assay               

       5.1.4 Enzyme-Linked Immunosorbent Assay       

       5.1.5 Liquid Chromatography-Mass Spectrometry            

       5.1.6 Particle-Enhanced Turbidimetric Immunoassay      

       5.1.7  Y-o-Y Growth Analysis, By Diagnostic Technique   

       5.1.8  Market Attractiveness Analysis, By Diagnostic Technique

       5.1.9  Market Share Analysis, By Diagnostic Technique   

                5.2 Type     

       5.2.1 Introduction           

       5.2.2 Up-Regulated Proteins      

                       5.2.2.1 Interleukin 18

                       5.2.2.2 Kidney injury molecule 1

                       5.2.2.3 Neutrophil gelatinase-associated lipocalin

       5.2.3 Functional Biomarker         

                       5.2.3.1 Serum Creatinine

                       5.2.3.2 Serum Cystatin C

                       5.2.3.3 Urine Albumin

       5.2.4 Others      

       5.2.5 Y-o-Y Growth Analysis, By Type     

       5.2.6 Market Attractiveness Analysis, By Type   

       5.2.7 Market Share Analysis, By Type     

                5.3 End User                      

       5.3.1 Introduction           

       5.3.2 Diagnostic Labs      

       5.3.3 Hospitals  

       5.3.4 Outpatient Clinics 

       5.3.5 Research Centres 

       5.3.6 Y-o-Y Growth Analysis, By End User             

       5.3.7  Market Attractiveness Analysis, By End User          

       5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Diagnostic Technique

                       6.1.3.3 By Type

                       6.1.3.4 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Diagnostic Technique

                       6.1.4.3 By Type

                       6.1.4.4 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Diagnostic Technique

                       6.1.5.3 By Type

                       6.1.5.4 By End User

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia       

                6.7 Rest of APAC               

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Thermo Fisher Scientific Inc                 

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Abbott Laboratories      

                8.3 Beckman Coulter, Inc.   

                8.4 Randox Laboratories Ltd                       

                8.5 Astute Medical Inc.                 

                8.6 F. Hoffmann-La Roche AG                    

                8.7 Siemens Healthcare Diagnostics Inc.                

                8.8 Alere Inc.                     

                8.9 bioMérieux SA

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  1. Asia Pacific Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  2. Asia Pacific Enzyme-Linked Immunosorbent Assay Market By Region, From 2022 - 2027 ( USD Million )
  3. Asia Pacific Chemiluminescent Enzyme Immunoassay Market By Region, From 2022 - 2027 ( USD Million )
  4. Asia Pacific Colorimetric Assay Market By Region, From 2022 - 2027 ( USD Million )
  5. Asia Pacific Liquid Chromatography-Mass Spectrometry Market By Region, From 2022 - 2027 ( USD Million )
  6. Asia Pacific Particle-Enhanced Turbidimetric Immunoassay Market By Region, From 2022 - 2027 ( USD Million )
  7. Asia Pacific Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  8. Asia Pacific Up-Regulated Proteins Market By Region, From 2022 - 2027 ( USD Million )
  9. Asia Pacific Functional Biomarker Market By Region, From 2022 - 2027 ( USD Million )
  10. Asia Pacific Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )
  11. Asia Pacific Diagnostic Labs Market By Region, From 2022 - 2027 ( USD Million )
  12. Asia Pacific Hospitals Market By Region, From 2022 - 2027 ( USD Million )
  13. Asia Pacific Outpatient Clinics Market By Region, From 2022 - 2027 ( USD Million )
  14. Asia Pacific Research Centres Market By Region, From 2022 - 2027 ( USD Million )
  15. Japan Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  16. Japan Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  17. Japan Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )
  18. China Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  19. China Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  20. China Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )
  21. India Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  22. India Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  23. India Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )
  24. Australia Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  25. Australia Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  26. Australia Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )
  27. South Korea Renal Biomarker Market By Diagnostic Technique, From 2022 - 2027 ( USD Million )
  28. South Korea Renal Biomarker Market By Biomarker Type, From 2022 - 2027 ( USD Million )
  29. South Korea Renal Biomarker Market By End User, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample